Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,123 | 25 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $682.93 | 12 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $246.44 | 7 | $0 (2021) |
| BTG INTERNATIONAL, INC. | $89.32 | 1 | $0 (2020) |
| La Jolla Pharmaceutical Company | $43.13 | 1 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $34.41 | 2 | $0 (2024) |
| Inari Medical, Inc. | $13.76 | 1 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $12.83 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $143.48 | 2 | AstraZeneca Pharmaceuticals LP ($122.83) |
| 2023 | $138.48 | 2 | AstraZeneca Pharmaceuticals LP ($124.72) |
| 2022 | $246.96 | 4 | AstraZeneca Pharmaceuticals LP ($220.37) |
| 2021 | $336.28 | 12 | AstraZeneca Pharmaceuticals LP ($215.01) |
| 2020 | $102.05 | 2 | BTG INTERNATIONAL, INC. ($89.32) |
| 2019 | $155.57 | 3 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($112.44) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/12/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/11/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $122.83 | General |
| Category: Rare Disease | ||||||
| 09/14/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $124.72 | General |
| Category: Rare Disease | ||||||
| 06/08/2023 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: VTE | ||||||
| 08/25/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/14/2022 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $112.18 | General |
| Category: Rare Disease | ||||||
| 03/10/2022 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $108.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/21/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.83 | General |
| Category: Cardiovascular | ||||||
| 12/22/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/20/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Gastroenterology | ||||||
| 11/12/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $80.05 | General |
| Category: Gastroenterology | ||||||
| 10/13/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/08/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: Gastroenterology | ||||||
| 07/09/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/26/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/20/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: Gastroenterology | ||||||
| 05/13/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $118.27 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/27/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/05/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/20/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $12.94 | General |
| 08/05/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/12/2020 | BTG INTERNATIONAL, INC. | CROFAB (Drug) | Food and Beverage | Cash or cash equivalent | $89.32 | General |
| Category: ANTI-VENOM | ||||||
| 11/14/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $102.25 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/03/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), RELISTOR | Food and Beverage | In-kind items and services | $10.19 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/10/2019 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $43.13 | General |
| Category: GIAPREZA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 677 | 725 | $641,404 | $63,963 |
| 2022 | 8 | 542 | 570 | $273,196 | $61,717 |
| 2021 | 5 | 218 | 229 | $88,803 | $14,132 |
| 2020 | 4 | 246 | 251 | $196,066 | $21,746 |
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 337 | 371 | $451,811 | $44,698 | 9.9% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 104 | 105 | $85,901 | $8,476 | 9.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 47 | 48 | $60,351 | $7,210 | 11.9% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 36 | 40 | $23,332 | $1,968 | 8.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 142 | 150 | $12,000 | $913.39 | 7.6% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2023 | 11 | 11 | $8,009 | $697.56 | 8.7% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 255 | 270 | $146,683 | $36,640 | 25.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 81 | 87 | $64,293 | $14,097 | 21.9% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 60 | 61 | $29,142 | $5,472 | 18.8% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 51 | 52 | $16,213 | $2,484 | 15.3% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 13 | 16 | $5,248 | $1,347 | 25.7% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2022 | 11 | 12 | $4,385 | $782.41 | 17.8% |
| 99282 | Emergency department visit for problem of mild to moderate severity | Facility | 2022 | 18 | 18 | $3,860 | $567.82 | 14.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 53 | 54 | $3,373 | $327.14 | 9.7% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 52 | 52 | $28,299 | $4,614 | 16.3% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 27 | 28 | $23,725 | $4,533 | 19.1% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 71 | 74 | $28,708 | $3,970 | 13.8% |
| 99282 | Emergency department visit, low to moderately severe problem | Facility | 2021 | 20 | 22 | $5,021 | $679.65 | 13.5% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 48 | 53 | $3,051 | $334.88 | 11.0% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 89 | 91 | $121,231 | $12,541 | 10.3% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 65 | 66 | $41,055 | $5,564 | 13.6% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 74 | 75 | $32,754 | $3,514 | 10.7% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 18 | 19 | $1,026 | $127.29 | 12.4% |
About Spenser Rentz
Spenser Rentz is a Emergency Medicine healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/11/2018. The National Provider Identifier (NPI) number assigned to this provider is 1548767098.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Spenser Rentz has received a total of $1,123 in payments from pharmaceutical and medical device companies, with $143.48 received in 2024. These payments were reported across 25 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($1,123).
As a Medicare-enrolled provider, Rentz has provided services to 1,683 Medicare beneficiaries, totaling 1,775 services with total Medicare billing of $161,559. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Location Oklahoma City, OK
- Active Since 04/11/2018
- Last Updated 10/05/2019
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1548767098
Products in Payments
- ANDEXXA (Biological) $359.73
- LOKELMA (Drug) $310.26
- RELISTOR (Drug) $236.25
- CROFAB (Drug) $89.32
- GIAPREZA (Drug) $43.13
- XARELTO (Drug) $34.41
- FLOWTRIEVER CATHETER, S (Device) $13.76
- ELIQUIS (Drug) $12.83
- XIFAXAN (Drug) $10.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Oklahoma City
Alexander Frank, M.d, M.D
Emergency Medicine — Payments: $3.1M
Mohammad Razaq, M.d, M.D
Emergency Medicine — Payments: $177,813
Jose Borrego Acosta, Md, MD
Emergency Medicine — Payments: $76,213
Lindsey Epperson
Emergency Medicine — Payments: $36,931
Dr. Tyson Quy, M.d, M.D
Emergency Medicine — Payments: $35,983
Michael Partin, M.d, M.D
Emergency Medicine — Payments: $10,117